BRIEF

on HYBRIGENICS (EPA:ALHYG)

Strategic partnership between Logical Biological and B Cell Design

ATON SA welcomes the strategic agreement between Logical Biological and B Cell Design. Logical Biological, renowned for its critical biological materials, is partnering with B Cell Design, which specializes in human Fc monoclonal antibodies. These innovative antibodies represent a major technological breakthrough in diagnostics, combining the complexity and relevance of pathological plasma, while being sustainable and ethical. B Cell Design thus benefits from enhanced access to the global market, meeting a growing demand for reliable alternative solutions. Léone Atayi, President of ATON, emphasizes the importance of this partnership for diagnostic safety and innovation in public health.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all HYBRIGENICS news